Telomere length is a critical determinant for survival in multiple myeloma

British Journal of Haematology

Volumn 178, Issue 1, 2017, Pages 94-98

  Hyatt, Sam ^a   Jones, Rhiannon E ^a   Heppel, Nicole H ^a   Grimstead, Julia W ^a   Fegan, Chris ^a   Jackson, Graham H ^b   Hills, Robert ^a   Allan, James M ^c   Pratt, Guy ^d   Pepper, Chris ^a   Baird, Duncan M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

genome instability; multiple myeloma; prognosis; telomere

Indexed keywords

AGE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; COHORT ANALYSIS; HUMAN; MULTIPLE MYELOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; TELOMERE LENGTH; GENETICS; GENOMIC INSTABILITY; KAPLAN MEIER METHOD; MONOCLONAL IMMUNOGLOBULINEMIA; PATHOLOGY; PROGNOSIS; TELOMERE SHORTENING;

DNA;

DNA, NEOPLASM; GENOMIC INSTABILITY; HUMANS; KAPLAN-MEIER ESTIMATE; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA; NEOPLASM STAGING; PROGNOSIS; TELOMERE SHORTENING;

EID: 85016425533     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14643     Document Type: Article

References (15)

1. Artandi, S.E., Chang, S., Lee, S.L., Alson, S., Gottlieb, G.J., Chin, L. & DePinho, R.A. (2000) Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature, 406, 641–645.
2. Capper, R., Britt-Compton, B., Tankimanova, M., Rowson, J., Letsolo, B., Man, S., Haughton, M. & Baird, D.M. (2007) The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes & Development, 21, 2495–2508.
3. Greipp, P.R., San Miguel, J., Durie, B.G., Crowley, J.J., Barlogie, B., Blade, J., Boccadoro, M., Child, J.A., Avet-Loiseau, H., Kyle, R.A., Lahuerta, J.J., Ludwig, H., Morgan, G., Powles, R., Shimizu, K., Shustik, C., Sonneveld, P., Tosi, P., Turesson, I. & Westin, J. (2005) International staging system for multiple myeloma. Journal of Clinical Oncology, 23, 3412–3420.
4. Jones, C.H., Pepper, C. & Baird, D.M. (2012) Telomere dysfunction and its role in haematological cancer. British Journal of Haematology, 156, 573–587.
5. Jones, R.E., Oh, S., Grimstead, J.W., Zimbric, J., Roger, L., Heppel, N.H., Ashelford, K.E., Liddiard, K., Hendrickson, E.A. & Baird, D.M. (2014) Escape from telomere-driven crisis is DNA ligase III dependent. Cell Reports, 8, 1063–1076.
6. Klewes, L., Vallente, R., Dupas, E., Brand, C., Grun, D., Guffei, A., Sathitruangsak, C., Awe, J.A., Kuzyk, A., Lichtensztejn, D., Tammur, P., Ilus, T., Tamm, A., Punab, M., Rubinger, M., Olujohungbe, A. & Mai, S. (2013) Three-dimensional nuclear telomere organization in multiple myeloma. Translational Oncology, 6, 749–756.
7. Letsolo, B.T., Rowson, J. & Baird, D.M. (2010) Fusion of short telomeres in human cells is characterised by extensive deletion and microhomology and can result in complex rearrangements. Nucleic Acids Research, 38, 1841–1852.
8. Lin, T.T., Letsolo, B.T., Jones, R.E., Rowson, J., Pratt, G., Hewamana, S., Fegan, C., Pepper, C. & Baird, D.M. (2010) Telomere dysfunction and fusion during the progression of chronic lymphocytic leukaemia: evidence for a telomere crisis. Blood, 116, 1899–1907.
9. Lin, T.T., Norris, K., Heppel, N.H., Pratt, G., Allan, J.M., Allsup, D.J., Bailey, J., Cawkwell, L., Hills, R., Grimstead, J.W., Jones, R.E., Britt-Compton, B., Fegan, C., Baird, D.M. & Pepper, C. (2014) Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease. British Journal of Haematology, 167, 214–223.
10. Muezzinler, A., Zaineddin, A.K. & Brenner, H. (2013) A systematic review of leukocyte telomere length and age in adults. Ageing Research Reviews, 12, 509–519.
11. Palumbo, A., Avet-Loiseau, H., Oliva, S., Lokhorst, H.M., Goldschmidt, H., Rosinol, L., Richardson, P., Caltagirone, S., Lahuerta, J.J., Facon, T., Bringhen, S., Gay, F., Attal, M., Passera, R., Spencer, A., Offidani, M., Kumar, S., Musto, P., Lonial, S., Petrucci, M.T., Orlowski, R.Z., Zamagni, E., Morgan, G., Dimopoulos, M.A., Durie, B.G., Anderson, K.C., Sonneveld, P., San Miguel, J., Cavo, M., Rajkumar, S.V. & Moreau, P. (2015) Revised international staging system for multiple myeloma: a report from International myeloma working group. Journal of Clinical Oncology, 33, 2863–2869.
12. Roger, L., Jones, R.E., Heppel, N.H., Williams, G.T., Sampson, J.R. & Baird, D.M. (2013) Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability. Journal of the National Cancer Institute, 105, 1202–1211.
13. Simpson, K., Jones, R.E., Grimstead, J.W., Hills, R., Pepper, C. & Baird, D.M. (2015) Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients. Molecular Oncology, 9, 1186–1193.
14. Walker, B.A., Leone, P.E., Chiecchio, L., Dickens, N.J., Jenner, M.W., Boyd, K.D., Johnson, D.C., Gonzalez, D., Dagrada, G.P., Protheroe, R.K., Konn, Z.J., Stockley, D.M., Gregory, W.M., Davies, F.E., Ross, F.M. & Morgan, G.J. (2010) A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. Blood, 116, e56–e65.
15. Wu, K.D., Orme, L.M., Shaughnessy, J. Jr, Jacobson, J., Barlogie, B. & Moore, M.A. (2003) Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood, 101, 4982–4989.